image cutout quarter-circle featuring a table of healthcare providers talking; to the right is a blue background with medical supplies and text "DACS Digest" in black with a red star trailed by two parallel red lines underneath text

Bringing DC healthcare providers the latest news, events, and resources to improve care for patients with substance use disorders and chronic pain management.

February 2024

Education Opportunities

image of back of dr. weintraubs head and a patient on tele screen


Treatment for Opioid Use Disorder in Carceral Settings: Background, Implementation, Risk Mitigation, Acceptance

Tuesday, February 27 | 12:00 pm

Presented by DACS Medical Director, Eric Weintraub, MD

ASAM/AAAP Management of Stimulant Use Disorder Webinar Series

Stimulant Use Prevention and Harm Reduction


Wednesday, February 7 | 11:00 am - 12:00 pm


Grayken Center for Addiction Training & TA

The Nurse Care Manager Model of Office-Based Addiction Treatment


Thursday, February 8 | 12:00 pm - 4:00 pm


On Demand Webinars

DACS Webinar

The Pharmacist's Role in Increasing Access to Treatment of Opioid Use Disorder 


AIR CARES Webinar Series

Social Determinants of Addiction

Latest News & Research

Recruiting and Retaining a Diverse and Skilled Addiction Treatment Workforce


"In this Commentary, the authors discuss reasons for workforce shortages across roles, and offer recommendations for 8 areas of investment to grow and sustain a substance use and addiction care workforce prepared to address the overdose crisis in a racially equitable manner."



The misguided reason why providers aren’t prescribing more buprenorphine for opioid use disorder


Some providers cite diversion as a reason for not prescribing lifesaving buprenorphine, but a recent study highlighted in this article suggests that non-prescribed buprenorphine could be protective.



Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration

"The findings of this cross-sectional study suggest that policies tailored to specific clinical settings may be associated with reduced lengths of opioid prescriptions".


Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality


In this cohort study, no observable correlation was identified between cannabis regulations and opioid prescriptions or fatal opioid overdoses. However, the findings suggest a potential decrease in synthetic opioid fatalities linked to the implementation of recreational cannabis laws.


The DACS phone line will be closed on the following holidays:

February 19 - Presidents' Day

Relevant Resources to Support You

Treating Opioid Use Disorder in General Practice: Diagnosis, Harm Reduction, and Medications 

Sesame Street Parental Addiction Resources for Providers 

Call1-866-337-DACS (3227)to request a copy of the Parental Addiction book for your office

Webinars on Children and Families Affected by Parental Substance Use Disorders

1-866-337-DACS (3227) | |